Global PCR Technologies Market (2020 to 2025) - Shift from Plant-Derived to Genome-Based Drug Discovery Presents Opportunities
07 May 2021
mRNA
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Global PCR Technologies Market by Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene Expression, Diagnostics), End-user (Academia, Pharma-Biotech, Applied), and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global PCR technologies market is projected to reach USD 9.8 billion by 2025 from USD 7.2 billion in 2020, at a CAGR of 6.3% from 2020 to 2025.
The rising incidence of infectious diseases and genetic disorders across the world has spurred the demand for better and faster diagnostic tests. This has also boosted the overall pace of R&D in the PCR technologies market along with the availability of strong financial support in the form of investments, funds, and grants. These factors are driving the growth of PCR technologies market during the forecast period. However, high instrument costs - especially that of dPCR - and the technical limitations of PCR are expected to limit market growth to a certain extent.
The qPCR segment is expected to account for the largest market share of the global PCR technologies market in 2020
The qPCR segment is expected to account for the largest share among PCR techniques in 2020. The expanding applications of qPCR (owing to its technological benefits over traditional PCR, such as real-time analysis and reduced analysis time), growing private-public funding for life sciences research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples) are expected to drive the growth of the qPCR market.
Reagents and consumables segment to show the highest growth in the PCR technologies market during the forecast period
The reagents and consumables segment will show the highest growth in the PCR technologies market during the forecast period. The growth of this segment can be attributed to factors such as the expanding applications of dPCR, the increasing number of dPCR-based analytical procedures among institutional researchers (such as CROs and pharma-biotech companies), and the rising availability of novel dPCR reagents worldwide. Additionally, the expansion of the application base of the dPCR technology in genetic/molecular research, clinical diagnosis, and forensics is expected to result in the commercialization of novel dPCR reagents.
North America to account for the largest share of the global market in 2020
North America accounts for the largest share of the PCR technologies market owing to the high incidence of chronic and genetic diseases, rising geriatric population, growing adoption of PCR techniques in research & academia, and significant public-private funding in the field of genome analysis. Further, the strong presence of major pharmaceutical and biotechnology companies in the US and ongoing initiatives by the Canadian government to support life science, genomic, and clinical research are other few factors influencing the demand for PCR products in this region.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights4.1 PCR Technologies Market Overview4.2 PCR Technologies Market Share, by Technique, 2020 Vs. 20254.3 PCR Technologies Market, by Application, 2020 Vs. 2025 (USD Million)4.4 PCR Technologies Market, by Region, 2020-2025
5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Key Market Drivers5.2.1.1 Rising Incidence of Target Infectious Diseases and Genetic Disorders5.2.1.2 Continuous Advancements in PCR Technologies5.2.1.3 Increasing Investments, Funds, and Grants5.2.1.4 Increasing Use of Biomarker Profiling for Disease Diagnostics5.2.1.5 Successful Completion of the Human Genome Project5.2.2 Key Market Restraints5.2.2.1 High Device Costs Associated with dPCR5.2.2.2 Technical Limitations of qPCR and dPCR5.2.3 Key Market Opportunities5.2.3.1 Growing Market Penetration in Emerging Countries5.2.3.2 Shift from Plant-Derived to Genome-Based Drug Discovery5.2.4 Key Market Challenges5.2.4.1 Adoption and Implementation of MIQE Guidelines5.2.5 Key Market Trends5.2.5.1 Development of Compact, Portable, and Lab-On-Chip PCR Devices5.2.5.2 Ongoing Technological Integration with the PCR Process5.3 Industry Trends Related to COVID-195.4 Global Regulatory Scenario5.5 Ecosystem: Parent Market5.6 Porter's Five Forces Analysis5.6.1 Degree of Competition5.6.2 Bargaining Power of Suppliers5.6.3 Bargaining Power of Buyers5.6.4 Threat of New Entrants5.6.5 Threat of Substitutes
6 PCR Technologies Market, by Technique6.1 Introduction6.2 Conventional PCR6.2.1 High Adoption of this Technique and Its Diverse Applications to Sustain Market Growth6.3 Real-Time PCR6.3.1 Growing Adoption Among Researchers and Healthcare Professionals to Fuel Market Growth6.4 Digital PCR6.4.1 Ongoing Technological Developments with Respect to Digital PCR to Drive Market Growth6.5 Reverse Transcription PCR6.5.1 Higher Sensitivity for mRNA Detection is a Major Contributing Factor to Market Growth6.6 Hot-Start PCR6.6.1 Hassle-Free Setup of Samples is a Key Advantage Offered by this Technique6.7 Multiplex PCR6.7.1 Cost-Effectiveness of this Technique to Drive Market Growth6.8 Other PCR Techniques
7 PCR Technologies Market, by Product Type7.1 Introduction7.2 Instruments7.2.1 Increasing Availability of Innovative PCR Instruments Will Drive Market Growth7.3 Reagents and Consumables7.3.1 Increasing Number of Analytical Procedures Among Researchers to Fuel Market Growth7.4 Software and Services7.4.1 Automation and Digitalization of Laboratory Processes to Fuel Adoption Among End-users
8 PCR Technologies Market, by Application8.1 Introduction8.2 Gene Expression Analysis8.2.1 Gene Expression Analysis is Used in Epigenetics, SIRNA Quantification, mRNA Analysis, and Cell Line Validation8.3 Genetic Sequencing8.3.1 Reduced Cost of Sequencing to Drive Market Growth8.4 Genotyping8.4.1 SNP Genotyping Can Accelerate the Era of Personalized Medicine8.5 Nucleic Acid Detection8.5.1 PCR Techniques Have Wide Applications in Nucleic Acid Detection8.6 Nucleic Acid Synthesis8.6.1 DNA Synthesis Has Opened Avenues for Progress in Biology8.7 Standard Validation/Verification8.7.1 PCR Techniques are Used for Regional/Global Validation to Frame Commercial/Non-Commercial Guidelines8.8 Diagnostic Applications8.8.1 Diagnostic Applications Segment Accounted for the Largest Share of the Market8.9 Environmental Applications8.9.1 PCR is the Most Sensitive Technique to Detect Pathogens in Environmental Samples8.10 Other Applications
9 PCR Technologies Market, by End-user9.1 Introduction9.2 Hospitals and Diagnostic Centers9.2.1 High Prevalence of Target Diseases to Drive Market Growth9.3 Healthcare Industry9.3.1 PCR Has Wide Applications in the Healthcare Industry9.4 Academia and Government Organizations9.4.1 Availability of Cost-Effective and Innovative PCR Products to Drive Adoption9.5 Pharma-Biotech Companies9.5.1 Increasing R&D Initiatives by Pharma-Biotech Companies to Fuel the Adoption of PCR Technologies9.6 Applied Industries9.6.1 Increasing Environmental Regulations to Drive the Adoption of PCR Techniques9.7 Other End-users
10 PCR Technologies Market, by Region10.1 Introduction10.2 North America10.2.1 US10.2.1.1 Growing Adoption of PCR Techniques in Research & Academia to Drive Market Growth10.2.2 Canada10.2.2.1 Government Initiatives for Supporting Genomics Research to Drive Market Growth in Canada10.3 Europe10.3.1 Germany10.3.1.1 Large-Scale Outsourcing of Clinical Diagnostic Testing by Hospitals to Drive Market Growth10.3.2 UK10.3.2.1 Growing Focus on Genomics Research to Support Market Growth in the UK10.3.3 France10.3.3.1 Initiatives for Developing Genomic Medicine to Support Market Growth in France10.3.4 Italy10.3.4.1 Increasing R&D Investments by Pharmaceutical Companies to Propel Market Growth10.3.5 Spain10.3.5.1 Increasing Prevalence of Chronic and Infectious Diseases to Drive Market Growth10.3.6 Rest of Europe10.4 Asia-Pacific10.4.1 Japan10.4.1.1 Strong Research and Healthcare Infrastructure to Support Market Growth in Japan10.4.2 China10.4.2.1 Healthcare Infrastructure Modernization to Support Market Growth in China10.4.3 India10.4.3.1 Presence of a Large Target Patient Population to Support Market Growth in India10.4.4 Australia10.4.4.1 High Healthcare Expenditure in the Country to Support Market Growth10.4.5 South Korea10.4.5.1 Growing Number of Private Hospitals and Independent Testing Laboratories to Drive Market Growth10.4.6 Rest of Asia-Pacific10.5 Latin America10.5.1 Brazil10.5.1.1 Brazil is Expected to Dominate the LATAM Market10.5.2 Mexico10.5.2.1 Favorable Trade Agreements Will Support Imports and Improve the Accessibility to PCR Instruments in Mexico10.5.3 Rest of Latin America10.6 Middle East and Africa10.6.1 Low Purchasing Power of End-users and Infrastructural Limitations to Restrain Market Growth in the MEA
11 Competitive Landscape11.1 Overview11.2 Global Market Share Analysis11.2.1 Global PCR Technologies Market Share Analysis (2019)11.3 Competitive Leadership Mapping11.3.1 Stars11.3.2 Emerging Leaders11.3.3 Pervasive11.3.4 Participants11.4 Competitive Scenario
12 Company Profiles12.1 Key Players12.1.1 Thermo Fisher Scientific, Inc.12.1.1.1 Products & Services Offered12.1.1.2 Recent Developments12.1.1.3 Analyst's View12.1.2 F. Hoffman-La Roche Ltd.12.1.2.1 Products & Services Offered12.1.2.2 Recent Developments12.1.3 Bio-Rad Laboratories, Inc.12.1.3.1 Products & Services Offered12.1.3.2 Recent Developments12.1.3.3 Analyst's View12.1.4 Qiagen N.V.12.1.4.1 Products Offered12.1.4.2 Recent Developments12.1.5 Takara Bio, Inc.12.1.5.1 Products Offered12.1.5.2 Recent Developments12.1.6 Agilent Technologies, Inc.12.1.6.1 Products Offered12.1.6.2 Recent Developments12.1.7 Biomerieux S.A.12.1.7.1 Products Offered12.1.7.2 Recent Developments12.1.8 Fluidigm Corporation12.1.8.1 Products Offered12.1.8.2 Recent Developments12.1.9 Danaher Corporation12.1.9.1 Products Offered12.1.9.2 Recent Developments12.1.10 Abbott Laboratories12.1.10.1 Products Offered12.1.10.2 Recent Developments12.2 Other Players12.2.1 Merck KGaA12.2.1.1 Products & Services Offered12.2.1.2 Recent Developments12.2.2 Becton, Dickinson and Company12.2.2.1 Products Offered12.2.2.2 Recent Developments12.2.3 Promega Corporation12.2.3.1 Products Offered12.2.3.2 Recent Developments12.2.4 Eppendorf AG12.2.4.1 Products Offered12.2.4.2 Recent Developments12.2.5 Analytik Jena AG (A Wholly Owned Subsidiary of Endress+Hauser AG)12.2.5.1 Products Offered
13 Appendix13.1 Discussion Guide13.2 Knowledge Store: The Subscription Portal13.3 Available Customizations
For more information about this report visit
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.